2023 annual financial data
Ironwood Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -213.54%.
Operating income was -945,430,000 USD and net income was -1,002,239,000 USD.
Operating cash flow was 183,427,000 USD.
Get free Ironwood Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 442,735,000 USD
- Operating income
- -945,430,000 USD
- Net income
- -1,002,239,000 USD
- Operating cash flow
- 183,427,000 USD